Metipranolol-associated granulomatous iritis.
OBJECTIVE
Topical metipranolol therapy for primary open-angle glaucoma has been associated with anterior granulomatous uveitis in the United Kingdom. We studied granulomatous uveitis reactions to topical metipranolol 0.3% therapy for primary open-angle glaucoma in two patients in the United States.


METHODS
Two patients, aged 71 and 81 years, were given topical metipranolol 0.3% therapy for primary open-angle glaucoma.


RESULTS
Both developed granulomatous uveitis. The iritis was associated with an increase in intraocular pressure in both patients and resolved on discontinuation of the drug. One patient was inadvertently rechallenged with metipranolol, and the iritis recurred.


CONCLUSIONS
Topical metipranolol 0.3% therapy may be associated with the development of granulomatous uveitis and a paradoxical increase in intraocular pressure.
Melles
R B
RB
Department of Ophthalmology, Kaiser Permanente Medical Center, Redwood City, CA 94063.
Wong
I G
IG
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006099:Granuloma / Q000139:chemically induced*; D006801:Humans; D007500:Iritis / Q000139:chemically induced*; D008297:Male; D014290:Metipranolol / Q000009:adverse effects*
D014290:Metipranolol